PALISADE BIO, INC. (PALI) Financial Statements
PALISADE BIO, INC. (PALI) reported trailing twelve-month revenue of $0 (down 100.0% year on year) and net income of -$31.9M as of 2026-06-30, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PALIPALISADE BIO, INC.Follow PALI — free
—
Price chart with a free account
- Market cap
- 231.8M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.4 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.3 | 0.3 | 0.0 | 0.0 | — | — | 0.3 | 0.0 | 0.0 | — | |
| Research & development | 7.4 | 6.1 | 7.3 | 8.4 | 12.6 | 13.2 | 8.1 | 4.0 | 4.1 | 2.0 | 2.4 | 6.5 | 6.9 | 9.1 | 10.2 | 21.4 | |
| Operating income | -13.0 | -10.2 | -12.5 | -17.4 | -19.2 | -20.6 | -13.3 | -8.3 | -8.6 | -9.3 | -41.9 | -15.7 | -13.1 | -14.9 | -18.1 | -35.3 | |
| Pre-tax income | -12.5 | -10.1 | -19.8 | -22.6 | -20.9 | -21.1 | 3.6 | -7.7 | -7.9 | -10.3 | -26.6 | -14.3 | -12.3 | -14.4 | -16.8 | -31.9 | |
| Income tax | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | -12.5 | -10.1 | -19.8 | -22.6 | -20.9 | -21.1 | -15.7 | -4.9 | -8.4 | -10.3 | -26.6 | -14.3 | -12.3 | -14.4 | -16.8 | -31.9 | |
| Diluted EPS ($) | -0.26 | -0.17 | -0.27 | -0.26 | -2.99 | -2.53 | -1.20 | -7.54 | -3.80 | -1.17 | -169.74 | -16.53 | -27.01 | -10.19 | -0.30 | -0.15 | |
| Diluted shares (mn) | — | — | — | — | — | — | — | — | — | — | 0.2 | 0.9 | 0.5 | 1.4 | 55.7 | — |
USD millions · SEC XBRL
PALISADE BIO, INC. — questions
- What is PALISADE BIO, INC.'s revenue?
- $0 over the twelve months to 2026-06-30, down 100.0% year on year, from its 10-Q and 10-K filings.
- What is PALISADE BIO, INC.'s net income?
- -$31.9M over the twelve months to 2026-06-30.
- What are PALISADE BIO, INC.'s diluted earnings per share?
- $-0.15 over the twelve months to 2026-06-30.
Every figure on this page comes from PALISADE BIO, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.